Menopause Impact Scale and app tracking: Oura report guide

Quick answer: Oura’s Menopause Impact Scale (MIS) can help name how symptoms affect quality of life, but a score or partner report is not the same as a daily menopause log. In September 2026, Oura expanded MIS into clinical partner workflows (including Alloy, Gennev, Wisp, Pomelo, Maven, Tia, Xella, Oova, Mira, and Hertility). For follow-up prep, translate any MIS score or shared report into dates, symptom severity, sleep disruption, HRT context, bleeding changes, privacy/export notes, and practical questions. MIS scores do not diagnose menopause or replace clinician care.

Who this guide is for

This guide is for perimenopause and menopause women age 40-65 who are comparing tracking tools, preparing for a menopause or HRT follow-up, or trying to turn messy midlife symptoms into a clearer pattern. It is tracking-first, not medical advice.

Clinical partner reports vs your own timeline

Oura has announced MIS integrations with menopause care, primary/women’s health, and hormone-tracking partners such as Alloy, Gennev, Wisp, Pomelo, Maven, Tia, Xella, Oova, Mira, and Hertility. Availability and timing can change by partner.

If a partner asks you to share an MIS result or Oura-linked report:

• treat it as one appointment-context artifact, not a diagnosis
• keep a private Stabilize timeline of daily symptoms, sleep, bleeding, and HRT/medication context
• note what you shared, when, and which questions remain unanswered
• check privacy, account, and export settings before connecting apps

A partner report can help a clinician see quality-of-life impact. It still does not replace your dated symptom story.

What a score can do

• summarize how symptoms affect daily life
• prompt reflection on sleep, mood, body changes, and function
• give a shared language for clinicians and patients
• show that perimenopause can affect more than periods
• create a starting point for a deeper symptom log

What daily app tracking adds

• what happened on the worst days
• hot flash and night-sweat frequency
• sleep timing and next-day function
• bleeding or spotting details
• HRT or medication context beside symptom changes

A Stabilize-style tracking worksheet

Use this simple structure for the next two to four weeks:

• date and time window
• top symptoms with severity from 0 to 10
• sleep quality, wakeups, hot flashes, and night sweats
• bleeding, spotting, cycle uncertainty, vaginal, urinary, or pelvic symptoms when relevant
• HRT, medication, supplement, refill, patch-day, or routine context if relevant
• what changed since the last visit
• the two or three questions you most want answered

What to bring to a clinician

Bring a short summary first: the main symptom pattern, when it began, what seems connected, and how it affects sleep, work, caregiving, mood, sex, exercise, or daily responsibilities. Keep the raw notes available, but lead with the pattern.

FAQ

Is the Menopause Impact Scale a diagnosis?

No. Treat it as a structured questionnaire or context tool, not a diagnosis by itself.

Why log daily if I already have a score?

Daily notes explain the pattern behind the score: timing, severity, triggers, sleep, bleeding, and medication context.

How can Stabilize help Oura users?

Stabilize can sit beside wearable insights by organizing symptom and HRT context into a clinician-ready timeline.

Why Stabilize fits this use case

Stabilize helps turn daily perimenopause and menopause notes into a clear timeline: symptoms, sleep, bleeding, HRT context, refill friction, side-effect concerns, and clinician-ready summaries.

Related Stabilize guides

• Best perimenopause app with Oura, Apple Watch, or Garmin
• Oura Menopause Insights vs symptom tracker
• Best wearables for menopause tracking in 2026

Medical disclaimer: This content is for informational and tracking purposes only and does not constitute medical advice. Always consult qualified physicians for diagnosis and treatment decisions.